NeuroPace (NPCE) Capital Expenditures (2020 - 2026)
NeuroPace's quarterly Capital Expenditures came in at $114000.0 in Q1 2026, up 208.11% year-on-year from $37000.0 in Q1 2025, and up 850.0% quarter-over-quarter from $12000.0 in Q4 2025.
NeuroPace has reported Capital Expenditures for 7 years, with the latest figure at $114000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 208.11% year-over-year to $114000.0; the trailing twelve-month figure through Mar 2026 stood at $90000.0 (up 8900.0% YoY), and the FY2025 full-year result was $13000.0, down 31.58% from the prior year.
- Capital Expenditures for Q1 2026 stood at $114000.0, up from $12000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $470000.0 in Q3 2022, with the low at -$377000.0 in Q4 2022.
- Average Capital Expenditures over 5 years is $24214.3, with a median of $15500.0 recorded in 2024.
- Year-over-year, Capital Expenditures plunged 344.81% in 2022 and soared 325.81% in 2023.
- Tracing NPCE's Capital Expenditures over 5 years: stood at -$377000.0 in 2022, then soared by 80.9% to -$72000.0 in 2023, then surged by 126.39% to $19000.0 in 2024, then sank by 36.84% to $12000.0 in 2025, then soared by 850.0% to $114000.0 in 2026.
- The last three Capital Expenditures figures came in at $114000.0 (Q1 2026), $12000.0 (Q4 2025), and -$24000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 114,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114,000.00 |
| Mar 31, 2026 | 114,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Jun 30, 2025 | -12,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Jun 30, 2024 | -55,000.00 |
| Jun 30, 2024 | -55,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | -72,000.00 |
| Dec 31, 2023 | -72,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Sep 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Dec 31, 2022 | -377,000.00 |
| Dec 31, 2022 | -377,000.00 |
| Sep 30, 2022 | 470,000.00 |
| Sep 30, 2022 | 470,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Mar 31, 2022 | 31,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Dec 31, 2021 | 154,000.00 |
| Sep 30, 2021 | 230,000.00 |
| Sep 30, 2021 | 230,000.00 |
| Dec 31, 2020 | 62,000.00 |
| Dec 31, 2020 | 62,000.00 |
| Sep 30, 2020 | -16,000.00 |
| Sep 30, 2020 | -16,000.00 |
| Mar 31, 2020 | 16,000.00 |
| Mar 31, 2020 | 16,000.00 |